Selective inhibition of amine oxidases differently potentiate the hypophagic effect of benzylamine in mice.

[1]  G. Banchelli,et al.  Benzylamine-related compounds stimulate rat vas deferens neurotransmission and potentiate memory in the mouse acting as potassium channel blockers. , 2000, Pharmacological research.

[2]  J. Lizcano,et al.  Semicarbazide-sensitive amine oxidase (SSAO) from human and bovine cerebrovascular tissues: biochemical and immunohistological characterization , 1998, Neurochemistry International.

[3]  F. Boomsma,et al.  Deamination of methylamine and aminoacetone increases aldehydes and oxidative stress in rats. , 1998, Life sciences.

[4]  S. Caccia,et al.  Citalopram‐induced hypophagia is enhanced by blockade of 5‐HT1A receptors: role of 5‐HT2C receptors , 1998, British journal of pharmacology.

[5]  P. Fletcher,et al.  Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine , 1998, Brain Research.

[6]  J. Knoll,et al.  (-)Deprenyl (selegiline), a catecholaminergic activity enhancer (CAE) substance acting in the brain. , 1998, Pharmacology & toxicology.

[7]  L. Schechter.  The potassium channel blockers 4-aminopyridine and tetraethylammonium increase the spontaneous basal release of [3H]5-hydroxytryptamine in rat hippocampal slices. , 1997, Journal of Pharmacology and Experimental Therapeutics.

[8]  S. Capaccioli,et al.  Effect of K+ channel modulation on mouse feeding behaviour. , 1997, European journal of pharmacology.

[9]  C. Routledge,et al.  Differential effects of potassium channel blockers on extracellular concentrations of dopamine and 5‐HT in the striatum of conscious rats , 1995, British journal of pharmacology.

[10]  J. Langston,et al.  Age-dependent effects of the 2'-methyl analog of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine: prevention by inhibitors of monoamine oxidase B. , 1995, The Journal of pharmacology and experimental therapeutics.

[11]  G. Olmos,et al.  The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline‐preferring receptors , 1995, British journal of pharmacology.

[12]  R. Matucci,et al.  Calcium modulatory properties of 2,6‐dibutylbenzylamine (B25) in rat isolated vas deferens, cardiac and smooth muscle preparations , 1993, British journal of pharmacology.

[13]  Philip S. Yu,et al.  Oxidative Deamination of Methylamine by Semicarbazide-Sensitive Amine Oxidase Leads to Cytotoxic Damage in Endothelial Cells: Possible Consequences for Diabetes , 1993, Diabetes.

[14]  M. Parada,et al.  Serotonin may play a role in the anorexia induced by amphetamine injections into the lateral hypothalamus , 1992, Brain Research.

[15]  J. Elliott,et al.  Effect of benzylamine and its metabolites on the responses of the isolated perfused mesenteric arterial bed of the rat. , 1991, Journal of autonomic pharmacology.

[16]  G. Banchelli,et al.  A study of the biochemical pharmacology of 3,5-ethoxy-4-aminomethylpyridine (B24), a novel amine oxidase inhibitor with selectivity for tissue bound semicarbazide-sensitive amine oxidase enzymes , 1990, Neurochemistry International.

[17]  N. S. Cook,et al.  Potassium Channels — Structure, Classification, Function and Therapeutic Potential Nigel S. Cook (ed.) Ellis Horwood, 1990. £59.95 (412 pages) ISBN 0 7458 0624 4 , 1990, Trends in Neurosciences.

[18]  B. Hoebel,et al.  Hypothalamic infusion of amphetamine increases serotonin, dopamine and norepinephrine , 1988, Physiology & Behavior.

[19]  K. Ramos,et al.  Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors. , 1988, Toxicology and applied pharmacology.

[20]  R. Pauwels,et al.  Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues. , 1988, Biochemical pharmacology.

[21]  M. Palfreyman,et al.  Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds. , 1987, Biochemical pharmacology.

[22]  L. Costa,et al.  A comparison of the antinociceptive responses to the GABA-receptor agonists THIP and baclofen , 1985, Neuropharmacology.

[23]  G. Willis,et al.  Anorexic properties of three monoamine oxidase inhibitors , 1982, Pharmacology Biochemistry and Behavior.

[24]  N. Gray,et al.  The effects of stereoisomers of 2- and 9- aminobenzonorbornenes on food intake, brain serotonin concentration and monoamine oxidase activity in the rat. , 1982, The Journal of pharmacology and experimental therapeutics.

[25]  S. O. Cole.  Brain mechanisms of amphetamine-induced anorexia, locomotion, and stereotypy: A review , 1978, Neuroscience & Biobehavioral Reviews.

[26]  A. Abdallah,et al.  Role of dopamine in the anorexigenic effect of DITA; comparison with d-amphetamine. , 1976, European journal of pharmacology.

[27]  T. Haley,et al.  Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. , 1957, British journal of pharmacology and chemotherapy.

[28]  E. Gibson,et al.  Appetite suppression by commonly used drugs depends on 5-HT receptors but not on 5-HT availability. , 1997, Trends in pharmacological sciences.

[29]  F. Buffoni.  Chapter 32 Semicarbazide-sensitive amine oxidases: some biochemical properties and general considerations , 1995 .

[30]  F. Buffoni.  Semicarbazide-sensitive amine oxidases: some biochemical properties and general considerations. , 1995, Progress in brain research.

[31]  J. Morley,et al.  The Pharmacology of Eating Behavior , 1985 .

[32]  P. Boor,et al.  Allylamine cardiotoxicity: III. Protection by semicarbazide and in vivo derangements of monoamine oxidase. , 1980, Toxicology.

[33]  M. Sandler,et al.  A benzylamine oxidase distinct from monoamine oxidase B--widespread distribution in man and rat. , 1978, Biochemical pharmacology.